Evidence map›Paper›PMID 32277855›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2020

Cholinergic neuroplasticity in asthma driven by TrkB signaling.

Guilherme Dragunas, Manon E Woest, Susan Nijboer, Sophie T Bos, Janet van Asselt, Anne P de Groot, Eva Vohlídalová, Corneel J Vermeulen, Benedikt Ditz, Judith M Vonk and 8 more

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. The Role of the Nervous System in Lung Disease.Current neurology and neuroscience reports · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Neuroplasticity and neuroimmune interactions with type 2 inflammation in asthma.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Guilherme DragunasDepartment of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.
Manon E WoestDepartment of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.
Susan NijboerDepartment of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.
Sophie T BosDepartment of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.
Janet van AsseltDepartment of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.
Anne P de GrootDepartment of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.
Eva VohlídalováDepartment of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.
Corneel J VermeulenGRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Benedikt DitzGRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Judith M VonkGRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Gerard H KoppelmanGRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Maarten van den BergeGRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Nick H T Ten HackenGRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Wim TimensGRIAC Research Institute, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Carolina D MunhozDepartment of Pharmacology, University of São Paulo, São Paulo, Brazil.
Y S PrakashDepartment of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
Reinoud GosensDepartment of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.
Loes E M KistemakerDepartment of Molecular Pharmacology, University of Groningen, Groningen, the Netherlands.
University of Groningen · NLUniversity Medical Center Groningen · NLDialyse Centrum Groningen · NLMayo Clinic in Arizona · USUniversidade de São Paulo · BR

Funding

Neurotrophins in the LungR01HL088029 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S. · 2009 to 2022
$5.9M
NHLBI NIH HHS R01 HL088029
6 · The paper itself

Abstract

Parasympathetic neurons in the airways control bronchomotor tone. Increased activity of cholinergic neurons are mediators of airway hyperresponsiveness (AHR) in asthma, however, mechanisms are not elucidated. We describe remodeling of the cholinergic neuronal network in asthmatic airways driven by brain-derived neurotrophic factor (BDNF) and Tropomyosin receptor kinase B (TrkB). Human bronchial biopsies were stained for cholinergic marker vesicular acetylcholine transporter (VAChT). Human lung gene expression and single nucleotide polymorphisms (SNP) in neuroplasticity-related genes were compared between asthma and healthy patients. Wild-type (WT) and mutated TrkB knock-in mice (Ntrk2tm1Ddg/J) with impaired BDNF signaling were chronically exposed to ovalbumin (OVA). Neuronal VAChT staining and airway narrowing in response to electrical field stimulation in precision cut lung slices (PCLS) were assessed. Increased cholinergic fibers in asthmatic airway biopsies was found, paralleled by increased TrkB gene expression in human lung tissue, and SNPs in the NTRK2 [TrkB] and BDNF genes linked to asthma. Chronic allergen exposure in mice resulted in increased density of cholinergic nerves, which was prevented by inhibiting TrkB. Increased nerve density resulted in AHR in vivo and in increased nerve-dependent airway reactivity in lung slices mediated via TrkB. These findings show cholinergic neuroplasticity in asthma driven by TrkB signaling and suggest that the BDNF-TrkB pathway may be a potential target.

Indexed as

AdolescentAnimalsAsthmaCase-Control StudiesCholinergic AgentsFemaleHumansInflammationLungMaleMembrane GlycoproteinsMiceMice, Inbred BALB CMuscle, SmoothNeuronal PlasticityOvalbuminCholinergic AgentsMembrane GlycoproteinsOvalbuminReceptor, trkBtropomyosin-related kinase-B, humanasthmalung innervationneuroplasticityneurotrophins

Identifiers

PMID32277855
PMCPMC7302963
OpenAlexW3016236927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.